Skip to content

COMMUPHAR: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

COMMUPHAR

BE 0444.231.888
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€22,058
2024 · €553-€22,611
Equity
-€272,787
2024 · -€250,729-€22,058
Cash
€25,650
2024 · €28,277-€2,627
Balance sheet total
€136,781
2024 · €137,354-€573

Largest movements

2024 to 2025
Assets
  • Stocks and contracts +€6,598

    up €6,598 (+12.1%), from €54,731 to €61,330

  • Receivables within one year -€4,791

    down €4,791 (-13.2%), from €36,262 to €31,472

    of which Trade receivables: -€4,818

  • Cash -€2,627

    down €2,627 (-9.3%), from €28,277 to €25,650

    mainly Net result for the year (-€22,058) and Stocks and contracts (-€6,598)

  • Current investments +€1,712

    new in 2025: €1,712

Equity and liabilities
  • Profit (loss) carried forward -€22,058

    down €22,058 (-5.9%), from -€376,211 to -€398,270

  • Other debts +€18,676

    up €18,676 (+5.6%), from €334,214 to €352,890

  • Accrued charges and deferred income +€2,785

    up €2,785 (+74.9%), from €3,716 to €6,501

  • Tax, wage and social debts +€1,731

    up €1,731 (+18.4%), from €9,419 to €11,150

    of which Remuneration and social security: +€1,703

  • Trade debts -€1,707

    down €1,707 (-4.2%), from €40,733 to €39,026

Income statement
  • Staff costs +€19,346

    up €19,346 (+27.4%), from €70,604 to €89,950

  • Gross operating margin -€3,678

    down €3,678 (-4.6%), from €79,321 to €75,643

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €553
Gross operating margin -€3,678
Staff costs -€19,346
Depreciation -€597
Other operating charges +€669
Financial income +€123
Financial charges +€218
Result 2025 -€22,058

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€1,336
Investment -€3,962
Financing €0
Cash 2024 €28,277
Net result for the year -€22,058
Depreciation +€2,489
Stocks and contracts -€6,598
Receivables within one year +€4,791
Deferred charges and accrued income +€1,228
Trade debts -€1,707
Tax, wage and social debts +€1,731
Other debts +€18,676
Accrued charges and deferred income +€2,785
Investment in fixed assets (net) -€2,250
Current investments -€1,712
Cash 2025 €25,650
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €137,354 €136,781 -€573 -0.4%
Fixed assets 21/28 €12,287 €12,049 -€239 -1.9%
Tangible fixed assets 22/27 €12,287 €12,049 -€239 -1.9%
Plant, machinery and equipment 23 €12,287 €12,049 -€239 -1.9%
Current assets 29/58 €125,067 €124,732 -€335 -0.3%
Stocks and contracts in progress 3 €54,731 €61,330 +€6,598 +12.1%
Stocks 30/36 €54,731 €61,330 +€6,598 +12.1%
Amounts receivable within one year 40/41 €36,262 €31,472 -€4,791 -13.2%
Trade receivables 40 €35,510 €30,692 -€4,818 -13.6%
Other amounts receivable 41 €752 €780 +€28 +3.7%
Current investments 50/53 - €1,712 +€1,712
Cash at bank and in hand 54/58 €28,277 €25,650 -€2,627 -9.3%
Deferred charges and accrued income 490/1 €5,797 €4,568 -€1,228 -21.2%
Total equity and liabilities 10/49 €137,354 €136,781 -€573 -0.4%
Equity 10/15 -€250,729 -€272,787 -€22,058 -8.8%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €63,483 €63,483 = 0.0%
Non-distributable reserves 130/1 €3,099 €3,099 = 0.0%
Legal reserve 130 €3,099 €3,099 = 0.0%
Distributable reserves 133 €60,384 €60,384 = 0.0%
Profit (loss) carried forward 14 -€376,211 -€398,270 -€22,058 -5.9%
Amounts payable 17/49 €388,083 €409,567 +€21,485 +5.5%
Amounts payable within one year 42/48 €384,367 €403,066 +€18,700 +4.9%
Trade debts 44 €40,733 €39,026 -€1,707 -4.2%
Suppliers 440/4 €40,733 €39,026 -€1,707 -4.2%
Taxes, remuneration and social security 45 €9,419 €11,150 +€1,731 +18.4%
Taxes 450/3 - €28 +€28
Remuneration and social security 454/9 €9,419 €11,122 +€1,703 +18.1%
Other amounts payable 47/48 €334,214 €352,890 +€18,676 +5.6%
Accrued charges and deferred income 492/3 €3,716 €6,501 +€2,785 +74.9%
Remuneration, social security and pensions 62 €70,604 €89,950 +€19,346 +27.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,891 €2,489 +€597 +31.6%
Other operating charges 640/8 €2,843 €2,175 -€669 -23.5%
Gross operating margin 9900 €79,321 €75,643 -€3,678 -4.6%
Operating profit (loss) 9901 €3,982 -€18,970 -€22,952
Financial income 75/76B €30 €152 +€123 +415.6%
Recurring financial income 75 €30 €152 +€123 +415.6%
Financial charges 65/66B €3,458 €3,240 -€218 -6.3%
Recurring financial charges 65 €3,458 €3,240 -€218 -6.3%
Profit (loss) for the period before taxes 9903 €553 -€22,058 -€22,611
Profit (loss) for the period 9904 €553 -€22,058 -€22,611
Profit (loss) for the period to be appropriated 9905 €553 -€22,058 -€22,611

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.